New patent for Purdue Pharma drug TARGINIQ

Annual Drug Patent Expirations for TARGINIQ
Annual Drug Patent Expirations for TARGINIQ

Targiniq is a drug marketed by Purdue Pharma Lp
and is included in one NDA. There are twenty patents protecting this drug.

This drug has two hundred and fifty-one patent family members in forty-five countries.

The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. Additional details are available on the naloxone hydrochloride; oxycodone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical drugs have the most drug patents in Slovenia?

This chart shows the drugs with the most patents in Slovenia.

Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

The companies with the greatest patent coverage in Slovenia are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical drugs have the most drug patents in Slovenia?

This chart shows the drugs with the most patents in Slovenia.

Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

The companies with the greatest patent coverage in Slovenia are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical companies have the most gum dosed drugs?

This chart shows the pharmaceutical companies with the most gum dosed drugs.

For a different perspective, see the most popular dosage types.

The companies with the most gum dosed drugs are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical companies have the most gum dosed drugs?

This chart shows the pharmaceutical companies with the most gum dosed drugs.

For a different perspective, see the most popular dosage types.

The companies with the most gum dosed drugs are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

New patent expiration for Elan Pharma drug EVAMIST

Annual Drug Patent Expirations for EVAMIST
Annual Drug Patent Expirations for EVAMIST

Evamist is a drug marketed by Elan Pharma Intl Ltd
and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug.

This drug has fifty patent family members in seventeen countries.

The generic ingredient in EVAMIST is estradiol. Three suppliers are listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

New patent expiration for Eli Lilly drug AXIRON

Annual Drug Patent Expirations for AXIRON
Annual Drug Patent Expirations for AXIRON

Axiron is a drug marketed by Eli Lilly And Co
and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.

This drug has eigthy-three patent family members in twenty countries.

The generic ingredient in AXIRON is testosterone. Two suppliers are listed for this compound. Additional details are available on the testosterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com